| Autor: |
Ascic E; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Åkerström F; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Sreekumar Nair M; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Rosa A; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Kurochkin I; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Zimmermannova O; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Catena X; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Rotankova N; InSphero AG, 8952 Schlieren, Switzerland., Veser C; InSphero AG, 8952 Schlieren, Switzerland., Rudnik M; InSphero AG, 8952 Schlieren, Switzerland., Ballocci T; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Schärer T; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Huang X; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., de Rosa Torres M; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Renaud E; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Velasco Santiago M; Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, 2730 Herlev, Denmark., Met Ö; Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Askmyr D; Department of Otorhinolaryngology, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.; Department of Clinical Sciences, Lund University, 221 84 Lund, Sweden., Lindstedt M; Department of Immunotechnology, Lund University, Medicon Village, 223 81 Lund, Sweden., Greiff L; Department of Otorhinolaryngology, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.; Department of Clinical Sciences, Lund University, 221 84 Lund, Sweden., Ligeon LA; InSphero AG, 8952 Schlieren, Switzerland., Agarkova I; InSphero AG, 8952 Schlieren, Switzerland., Svane IM; Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, 2730 Herlev, Denmark., Pires CF; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Rosa FF; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Pereira CF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden.; Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal. |
